- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07858474
Nutritional Assessment in Children With Cardiomyopathy
Nutritional Assessment in Children With Cardiomyopathy: Prevalence and Pattern of Malnutrition
This cross-sectional study aims to determine the prevalence and pattern of malnutrition (acute wasting, chronic stunting, and micronutrient deficiency) among children with cardiomyopathy attending the Pediatric Cardiology Unit at Assiut University Children's Hospital.
Study Overview
Status
Conditions
Detailed Description
Cardiomyopathy in children encompasses a heterogeneous group of primary myocardial disorders (dilated, hypertrophic, and restrictive) that represent a leading cause of chronic heart failure and a common indication for heart transplantation in the pediatric age group.
Malnutrition is now recognized as a common and clinically significant comorbidity in pediatric cardiomyopathy. Data from the Pediatric Cardiomyopathy Registry indicate that nearly a quarter of children with dilated cardiomyopathy are malnourished at presentation, while pooled estimates from adult heart failure populations report a malnutrition prevalence approaching half of all patients, with malnutrition independently associated with increased mortality.
This cross-sectional study will include children aged 1 month to 18 years with an established diagnosis of cardiomyopathy confirmed by echocardiography. Nutritional status will be assessed using anthropometric measurements (weight, height, MUAC, BMI-for-age z-scores), the STRONGkids screening tool, biochemical markers, and dietary assessment. The prevalence and pattern of malnutrition will be determined.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Manar Abd El-Aziz, Resident
- Phone Number: 01019138170
- Email: Manarabdelaziz057@gmail.com
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Children aged 1 month to 18 years with an established diagnosis of cardiomyopathy (dilated, hypertrophic, or restrictive) confirmed by echocardiography, attending or admitted to the Pediatric Cardiology Unit at Assiut University Children's Hospital.
Description
Inclusion Criteria:
- Children aged 1 month to 18 years.
- Established diagnosis of cardiomyopathy (dilated, hypertrophic, or restrictive) confirmed by echocardiography.
- Attending or admitted to the Pediatric Cardiology Unit at Assiut University Children's Hospital.
- Written informed consent from parent/legal guardian.
Exclusion Criteria:
- Known chronic conditions with an independent, primary effect on nutritional status (e.g., celiac disease, chronic kidney disease, malignancy).
- Genetic/metabolic syndromes with intrinsic growth failure unrelated to cardiac status.
- Refusal of parental/guardian informed consent.
Study Plan
How is the study designed?
Design Details
- Observational Models: CASE_ONLY
- Time Perspectives: CROSS_SECTIONAL
Cohorts and Interventions
Group / Cohort |
|---|
|
Children With Cardiomyopathy
Children aged 1 month to 18 years with an established diagnosis of cardiomyopathy (dilated, hypertrophic, or restrictive) confirmed by echocardiography, attending or admitted to the Pediatric Cardiology Unit at Assiut University Children's Hospital. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Title: Prevalence of malnutrition
Time Frame: Baseline
|
Proportion of children with cardiomyopathy who have malnutrition based on anthropometric z-scores according to WHO growth standards. |
Baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proportion of children at nutritional risk by STRONGkids
Time Frame: Baseline
|
Proportion of children classified as at nutritional risk according to the STRONGkids screening tool. |
Baseline
|
|
Mean left ventricular ejection fraction
Time Frame: Baseline
|
Mean left ventricular ejection fraction (LVEF) measured by echocardiography in percentage. |
Baseline
|
|
Mean serum albumin
Time Frame: Baseline
|
Mean serum albumin level in g/dL. |
Baseline
|
|
Mean body mass index for age z-score
Time Frame: Baseline
|
Mean BMI-for-age z-score according to WHO growth standards. |
Baseline
|
|
Proportion of children with feeding difficulties
Time Frame: Baseline
|
Proportion of children with reported feeding difficulties assessed by structured dietary assessment. |
Baseline
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Gamal A Asker, prof, Pediatrics Department, Assiut University Hospitals
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Nutrition-CMP-Assiut-2026
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.